Min Xiao

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 18

Top Topics

Intellectual Disability

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Neoadjuvant Chemotherapy

Top Venues

Journal of clinical immunology

Clinical & translational immunology

Therapeutic advances in hematology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jiachen Wang, Mi Zhou, Jianfeng Zhou, Min Xiao, Liang Huang
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. Journal of clinical immunology 44 (4) (2024)
Jiachen Wang, Mi Zhou, Jianfeng Zhou, Min Xiao, Liang Huang
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. Journal of clinical immunology 44 (4) (2024)
Jiachen Wang, Mi Zhou, Jianfeng Zhou, Min Xiao, Liang Huang
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. Journal of clinical immunology 44 (4) (2024)
Jiachen Wang, Mi Zhou, Jianfeng Zhou, Min Xiao, Liang Huang
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. Journal of clinical immunology 44 (4) (2024)
Jiachen Wang, Mi Zhou, Jianfeng Zhou, Min Xiao, Liang Huang
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. Journal of clinical immunology 44 (4) (2024)
Jiachen Wang, Mi Zhou, Jianfeng Zhou, Min Xiao, Liang Huang
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. Journal of clinical immunology 44 (4) (2024)
Jiachen Wang, Mi Zhou, Jianfeng Zhou, Min Xiao, Liang Huang
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. Journal of clinical immunology 44 (4) (2024)
Jiachen Wang, Mi Zhou, Jianfeng Zhou, Min Xiao, Liang Huang
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. Journal of clinical immunology 44 (4) (2024)
Jiachen Wang, Mi Zhou, Jianfeng Zhou, Min Xiao, Liang Huang
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. Journal of clinical immunology 44 (4) (2024)
Jiachen Wang, Mi Zhou, Jianfeng Zhou, Min Xiao, Liang Huang
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report. Journal of clinical immunology 44 (4) (2024)
Ting Deng, Shiyuan Zhang, Min Xiao, Jia Gu, Liang Huang, Hongping Ba
A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88 mut /CD79B mut diffuse large B-cell lymphoma. Cancer medicine 13 (4) (2024)
Zhe Li, Wei Mu, Min Xiao
Genetic lesions and targeted therapy in Hodgkin lymphoma. Therapeutic advances in hematology 14 (2023)
Kefeng Shen, Jiachen Wang, Kuangguo Zhou, Wei Mu, Meilan Zhang, Xinyue Deng, Haodong Cai, Wei Zhang, Wei Huang, Min Xiao
CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease. Clinical & translational immunology 12 (5) (2023)
Zhe Li, Wei Mu, Min Xiao
Genetic lesions and targeted therapy in Hodgkin lymphoma. Therapeutic advances in hematology 14 (2023)
Kefeng Shen, Jiachen Wang, Kuangguo Zhou, Wei Mu, Meilan Zhang, Xinyue Deng, Haodong Cai, Wei Zhang, Wei Huang, Min Xiao
CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease. Clinical & translational immunology 12 (5) (2023)
Yu Du, Ying Wang, Qinlu Li, Xiaona Chang, Kefeng Shen, Heng Zhang, Min Xiao, Shugang Xing
Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study. International journal of cancer (2023)
Kefeng Shen, Jiachen Wang, Kuangguo Zhou, Wei Mu, Meilan Zhang, Xinyue Deng, Haodong Cai, Wei Zhang, Wei Huang, Min Xiao
CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease. Clinical & translational immunology 12 (5) (2023)
Dan Li, Yimei Que, Shengnan Ding, Guang Hu, Wen Wang, Xia Mao, Ying Wang, Chun-Rui Li, Liang Huang, Jianfeng Zhou, Wei Zhang, Min Xiao
Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report. Journal for immunotherapy of cancer 10 (9) (2022)